Market Research Logo

The Worldwide Market for Prescription Cardiovascular Drugs

The worldwide market for prescription cardiovascular drugs encompasses a wide variety of products that treat the many facets of cardiovascular disease. The field of cardiology is currently experiencing a busy and dynamic period. As a result, the range of therapeutic options available to physicians has expanded significantly in the past few years and the development pipeline promises even more weapons soon. The sheer size and diversity of the current market and the potential of new products make this therapeutic category among the most competitive of prescription drug segments.

This comprehensive market study considers the following market segments:

  • Cardiac glycosides and positive inotropic agents
  • Antihypertensive agents
  • Antiarrhythmic agents
  • Vasodilators and peripheral vasodilator agents
  • Antihyperlipidemic agents
  • Blood modifiers
  • Diuretic agents
  • Other cardiovascular agents

Specific diseases and disorders discussed include:

  • Angina
  • Arrhythmia
  • Atherosclerosis
  • Congestive heart failure
  • Coronary artery disease
  • Hypertension
  • Myocardial infarction
  • Other disorders

The report details the various categories of cardiovascular drugs and describes U.S. and non-U.S. markets in each of the specific cardiovascular drug areas. Revenues are considered in each subsegment according to type of drug. In addition, top products in each category are reviewed. The report also covers market drivers and trends that are influencing the market. It further identifies major market factors, which are discussed in detail, and a total market summary is presented.

All market data are presented at the manufacturers’ level. Data are expressed in current U.S. dollars. The base year for data was 2004. Historical data are provided for 2002 and 2003, and forecast data are provided for each of the years 2005 through 2009. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2004 base year.

The information and analysis presented in this report are based on extensive interviews with senior management of top companies and other participants in the cardiovascular market. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals. Key information from published literature was used to conduct interviews with over 41 industry executives and product managers to validate and obtain expert opinion on current and future trends in the cardiovascular market. Interviews were also used to confirm and/or adjust market size estimates, as well as in formulating market projections.


  • Executive Summary
    • INTRODUCTION
    • SCOPE AND METHODOLOGY
    • SIZE AND GROWTH OF THE MARKET
      • Table Total World Prescription Cardiovascular Drug Market 2002-2009
    • ISSUES AND TRENDS AFFECTING MARKET
    • LEADING COMPETITORS
      • Table Top 17 Prescription Cardiovascular Drug Marketers: Cardiovascular Revenues and Segments of Participation 2004
  • Introduction
    • OVERVIEW OF THE CARDIOVASCULAR SYSTEM
      • Heart
      • Circulatory System
      • Cardiac Cycle
      • Coronary Circulation
      • Cardiac Myocytes
      • Contraction
      • Cardiac Energy Metabolism
      • Cardiac Output
    • CARDIOVASCULAR DISORDERS
      • Angina
      • Arrhythmias
      • Atherosclerosis
      • Congestive Heart Failure
      • Coronary Artery Disease
      • Hypertension
      • Myocardial Infarction
    • EFFECTS OF AGING
    • DEMOGRAPHICS
      • Table U.S. Prevalence, Incidence and Mortality of Selected Cardiovascular Conditions
    • DISEASE MANAGEMENT
  • Issues and Trends
    • IMMEDIATE STATIN USE INVESTIGATED
    • CLINICAL TRIAL IMAGE
    • INFLAMMATION REDUCTION
    • UNIQUE DRUG COMBINATIONS
    • ANTIHYPERTENSIVE BLOCKBUSTER
    • OTC STATINS
  • Prescription Cardiac Glycoside and Iontropic Drugs
    • OVERVIEW OF CARDIAC GLYCOSIDES AND INOTROPIC DRUGS
    • DESCRIPTION OF PRODUCTS
      • Table Currently Marketed Cardiac Glycosides and Inotropic Drugs
    • MARKET SIZE AND GROWTH
      • World Market
        • Table Total World Market for Cardiac Glycoside and Inotropic Drugs 2002-2009
      • The U.S. Market
        • Table Total U.S. Market for Cardiac Glycoside and Inotropic Drugs 2002-2009
      • Non-U.S. Market
        • Table Total Non-U.S. Market for Cardiac Glycoside and Inotropic Drugs 2002-2009
    • RESEARCH AND DEVELOPMENT
      • Table Cardiac Glycosides and Inotropic Agents in Development
    • COMPETITIVE ANALYSIS
      • Table Cardiac Glycoside and Inotropic Drug Revenues and Market Share by Supplier 2004
  • Prescription Antihypertensive Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • ACE Inhibitors
        • Table Currently Marketed ACE Inhibitors
      • Angiotensin II Receptor Antagonists
        • Table Currently Marketed Angiotensin II Receptor Antagonists
      • Adrenergic Blockers
      • Beta Blockers
        • Table Currently Marketed Adrenergic and Beta Blockers
      • Calcium Channel Blockers
        • Table Currently Marketed Calcium Channel Blockers
      • Combinations
        • Table Currently Marketed Combination Antihypertensives
    • MARKET SIZE AND GROWTH
      • World Market
        • Table Total World Market for Prescription Antihypertensive Drugs 2002-2009
        • Table World Market for Prescription Antihypertensive Drugs by Type (ACE Inhibitors, Angiotensin II Receptor Antagonists, Adrenergic Blockers, Beta Blockers, Calcium Channel Blockers, and Combinations) 2002-2009
      • U.S. Market
        • Table Total U.S. Prescription Antihypertensive Drug Market 2002-2009
      • Non-U.S. Market
        • Table Total Non-U.S. Prescription Antihypertensive Drug Market 20022009
    • RESEARCH AND DEVELOPMENT
      • Table Hypertensive Drugs in Development
    • COMPETITIVE ANALYSIS
      • Table Global Prescription Antihypertensive Drug Revenues and Market Share by Leading Supplier 2004
  • Prescription Antiarrhythmic Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Class I
      • Class II
      • Class III
        • Table Currently Marketed Antiarrhythmic Drugs
    • MARKET SIZE AND GROWTH
      • World Market
        • Table World Market for Prescription Antiarrhythmic Drugs 2002-2009
      • U.S. Market
        • Table U.S. Market for Prescription Antiarrhythmic Drugs 2002-2009
      • Non-U.S. Market
        • Table Total Non-U.S. Prescription Antiarrhythmic Drug Market 20022009
    • RESEARCH AND DEVELOPMENT
      • Table Antiarrhythmic Drugs in Development
    • COMPETITIVE ANALYSIS
      • Table Global Prescription Antiarrhythmic Drugs Revenues and Market Share by Leading Supplier 2004
  • Prescription Vasodilator and Peripheral Vasodilator Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Coronary Vasodilators
      • Natriuretic Peptides
      • Peripheral Vasodilators
        • Table Currently Marketed Vasodilator and Peripheral Vasodilator Drugs
    • MARKET SIZE AND GROWTH
      • World Market
        • Table World Market for Vasodilator and Peripheral Vasodilator Drugs 2002-2009
      • U.S. Market
        • Table Total U.S. Vasodilator and Peripheral Vasodilator Drugs Market 2002-2009
      • Non-U.S. Market
        • Table Total Non-U.S. Vasodilator and Peripheral Vasodilator Drugs Market 2002-2009
    • RESEARCH AND DEVELOPMENT
      • Table Vasodilator and Peripheral Vasodilator Drugs in Development
    • COMPETITIVE ANALYSIS
      • Table Global Vasodilator and Peripheral Vasodilator Drug Revenues and Market Share by Leading Supplier 2004
  • Prescription Antihyperlipidemic Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Bile Acid Sequestrants
      • Fibric Acid Derivatives
      • HMG-CoA Reductase Inhibitors (Statins)
      • Nicotinic Acid
        • Table Currently Marketed Antihyperlipidemic Drugs
    • MARKET SIZE AND GROWTH
      • World Market
        • Table World Market for Antihyperlipidemic Drugs 2002-2009
      • U.S. Market
        • Table U.S. Market for Prescription Antihyperlipidemic Drugs 2002-2009
      • Non-U.S. Market
        • Table Non-U.S. Market for Prescription Antihyperlipidemic Drugs 2002-2009
    • RESEARCH AND DEVELOPMENT
      • Table Antihyperlipidemic Drugs in Development
    • COMPETITIVE ANALYSIS
      • Table Global Prescription Antihyperlipidemic Drug Revenues and Market Share by Leading Supplier 2004
  • Prescription Blood Modifiers
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Anticoagulants
        • Table Currently Marketed Anticoagulant Drugs
      • Antiplatelets
        • Table Currently Marketed Antiplatelet Drugs
      • Thrombolytics
        • Table Currently Marketed Thrombolytic Drugs
    • MARKET SIZE AND GROWTH
      • World Market
        • Table World Market for Prescription Blood Modifier Drugs 2002-2009
      • U.S. Market
        • Table U.S. Prescription Blood Modifier Drug Market 2002-2009
      • Non-U.S. Market
        • Table Non-U.S. Prescription Blood Modifier Drug Market 2002-2009
        • Table Global Market for Prescription Blood Modifier Drugs by Type (Anticoagulants, Antiplatelets, Thrombolytics) 2002-2009
    • RESEARCH AND DEVELOPMENT
      • Table Blood Modifier Drugs in Development
    • COMPETITIVE ANALYSIS
      • Table Global Prescription Blood Modifier Revenues and Market Share by Leading Supplier 2004
  • Prescription Diuretic Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Carbonic Anhydrase Inhibitors
      • Loop
      • Potassium-Sparing
      • Thiazides
        • Table Currently Marketed Diurectic Drugs
    • MARKET SIZE AND GROWTH
      • World Market
        • Table World Market for Prescription Diuretic Drugs 2002-2009
      • U.S. Market
        • Table U.S. Prescription Diuretic Drugs Market 2002-2009
      • Non-U.S. Market
        • Table Non-U.S. Prescription Diuretic Drugs Market 2002-2009
    • RESEARCH AND DEVELOPMENT
      • Table Diuretic Drugs in Development
    • COMPETITIVE ANALYSIS
      • Table Global Prescription Diuretic Drug Revenues and Market Share by Leading Supplier 2004
  • Prescription Other Cardiovascular Drugs
    • OVERVIEW
    • DESCRIPTION OF PRODUCTS
      • Table Currently Marketed Other Cardiovascular Drugs
    • MARKET SIZE AND GROWTH
      • World Market
        • Table World Market for Other Cardiovascular Drugs 2002-2009
      • U.S. Market
        • Table U.S. Market for Other Cardiovascular Drugs 2002-2009
      • Non-U.S. Market
        • Table Non-U.S. Market for Other Cardiovascular Drugs 2002-2009
    • RESEARCH AND DEVELOPMENT
      • Table Other Cardiovascular Drugs in Development
    • COMPETITIVE ANALYSIS
      • Table World Market for Other Cardiovascular Drugs Revenues and Market Share by Leading Supplier 2004
  • World Market Summary
    • OVERVIEW
    • TOTAL MARKET SIZE AND FORECAST
      • Table Total World Market for Prescription Cardiovascular Drugs 2002-2009
      • Table World Market for Prescription Cardiovascular Drugs by Product Segment 2002-2009
    • COMPETITIVE ANALYSIS
      • Table World Market for Prescription Cardiovascular Drugs Revenues and Segments of Participation by Major Areas of Participation 2004
  • Corporate Profiles
    • ABBOTT LABORATORIES
    • ASTRAZENECA
    • BAYER CORPORATION
    • BIOVAIL CORPORATION
    • BOEHRINGER INGELHEIM GMBH
  • Selected Emerging Cardiovascular Company Briefs
  • Company Directory

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report